Skip to main content

Alwin Köhler takes professorial chair at MedUni Vienna

Research Group Leader at Max Perutz Labs becomes Professor of Molecular Biology
All News

(Vienna, 03 February 2020) Alwin Köhler, Research Group Leader at Max Perutz Labs took over a Chair in Molecular Biology at the Medical University of Vienna on 1 February 2020.

This is a joint Chair of MedUni Vienna and the University of Vienna at Max Perutz Labs.

Since 2010, Alwin Köhler has been a Group Leader at Max Perutz Labs, which is a joint research and teaching centre of the University of Vienna and the Medical University of Vienna at Vienna Biocenter. The main focus of his research is the study of nuclear pore complexes, the molecular gateways that are embedded in the nuclear envelope, where they control all transport between the nucleus and the cytoplasm. Apart from this transport function, the nuclear pores are also responsible for regulating gene expression and modelling the nuclear envelope that protects the genome.

About Alwin Köhler
Alwin Köhler was born in Brasov (Romania). He studied medicine at the University of Würzburg and graduated from the Department of Cell Biology of Harvard Medical School. Following a postdoctoral placement at Heidelberg University Biochemistry Center, he moved to Vienna in 2010 to work as a Group Leader at Max Perutz Labs, where he is currently Deputy Head. He has received an Austrian Science Fund START scholarship, an ERC Starting Grant and a NOMIS Pioneering Research Grant, inter alia. In 2017, he received a generous ERC Consolidator Grant for his studies into the nuclear pore complex and, in 2018, took over a Chair in Mechanistic Cell Biology at the Medical University of Vienna.

About Max Perutz Laboratories
Max Perutz Labs are a joint venture of the University of Vienna and the Medical University of Vienna. The institute carries out outstanding, internationally recognised research and teaching in the field of molecular biology. Max Perutz Labs scientists research fundamental, mechanistic processes in biomedicine and combine innovative basic research with questions of medical relevance.
Max Perutz Labs are part of Vienna BioCenter, a leading European hotspot for life sciences. Around 50 research groups with more than 450 employees from 40 different countries work at the institute. www.maxperutzlabs.ac.at